Pfizer (PFE) Surges 8%, Merck (MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.45 -1.25%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.6%
Join SI Premium – FREE
Pfizer (NYSE: PFE) Surges 8%, Merck (NYSE: MRK) Down 5% Following Pfizer's COVID-19 Oral Antiviral Treatment Data
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackrock Private Credit Fund Names Jason Mehring As CEO
- Grindr settles UK privacy lawsuit for £26 million
- Spartacus Metals holds AGM, all resolutions passed
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
